(Q54112242)

24 May 2018

title

Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. (English)

1 reference

24 May 2018

author name string

Yoshida N

1

1 reference

24 May 2018

Ikeda H

2

1 reference

24 May 2018

Wada T

3

1 reference

24 May 2018

Matsumoto A

4

1 reference

24 May 2018

Maki S

5

1 reference

24 May 2018

Muro A

6

1 reference

24 May 2018

Shibata A

7

1 reference

24 May 2018

Imaizumi T

8

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

24 May 2018

Journal of the American College of Cardiology

published in

1 reference

24 May 2018

volume

32

1 reference

24 May 2018

issue

7

1 reference

24 May 2018

page(s)

1938-1942

1 reference

24 May 2018

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Hypertrophie cardiomyopathy: A discussion of nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Improved diagnostic accuracy of thallium-201 stress test using multiple observers and criteria derived from interobserver analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Relationship of exercise or pacing induced ST segment depression and myocardial lactate metabolism in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Triple control of relaxation: implications in cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Mechanism of exercise hypotension in patients with ischemic heart disease. Role of neurocardiogenically mediated vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900498-7

7 January 2021

10.1016/S0735-1097(98)00498-7

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018